Based on advancements in drug therapy, a pharmaceutical company is developing Resithan, a new treatment for depression. A medical researcher for the company is studying the effectiveness of Resithan as compared to their existing drug, Exemor. A random sample of 414 depressed individuals is selected and treated with Resithan, and 177 find relief from their depression. A random sample of 448 depressed individuals is independently selected from the first sample and treated with Exemor, and 154 find relief from their depression. Based on the medical researcher's study, can we conclude, at the 0.05 level of significance, that the proportion p1 of all depressed individuals taking Resithan who find relief from depression is greater than the proportion p2 of all depressed individuals taking Exemor who find relief from depression? Perform a one-tailed test. Then complete the parts below. Carry your intermediate computations to three or more decimal places. (If necessary, consult a list of formulas.)